Error loading player: No playable sources found
Session II – Deep Dive Discussion
Date
June 8, 2021
This product is not available for individual purchase, but it is available as part of the following products:
The CGTP 2021 Symposium will explore how to continue to adapt concepts applied to other biologics and how to establish novel approaches where they are needed.
Panel Members
Biogen
CBER, FDA
CO.DON AG
bluebird bio, Inc.
Related Products
Session V – Case Studies from Global CGTP Submissions
This session will cover cell and gene therapy products in late stage of development and approved by the FDA and/or EMA to demonstrate the main CMC challenges, the regulatory framework, and the overall experience with the Health Authorities to bring these medicines to patients…
Session VI – Deep Dive Discussion
Join Session VI Deep Dive Panel Discussion [https://live.remo…
Session VII – Analytical Development Case Studies & Closing Remarks
Cell and gene therapy products represent a complex and evolving class of products where analytical development and characterization methods are not universally established and yet are critical to product development…
Session V – Deep Dive Discussion
Join Session V Deep Dive Panel Discussion [https://live.remo…
